Transfusion Medicine Reviews
Volume 21 , Pages S1-S2 , April 2007

Guidelines for the Use of Intravenous Immune Globulin for Hematologic and Neurologic Conditions

References 

  1. www.blood.ca/CentreApps/Internet/UW_V502_MainEngine.nsf/resources/Fractionation/$file/1_00-05_en.pdfAccessed Jan 24, 2007
  2. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Trans Med Rev. 2003;17:241–251
  3. Hamrock DJ. Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2006;6:535–542

PII: S0887-7963(07)00004-1

doi: 10.1016/j.tmrv.2007.01.003

Transfusion Medicine Reviews
Volume 21 , Pages S1-S2 , April 2007

Article Tools